0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Travelers Vaccines Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-26U371
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Travelers Vaccines Market Insights and Forecast to 2028

Global Travelers Vaccines Market Insights and Forecast to 2028

Code: QYRE-Auto-26U371
Report
January 2022
87 Pages
QYResearch
Region: Global, North America, China, Europe, France, Germany, Japan, Australia, India, Italy, Philippines, Malaysia, Thailand, South Korea, Saudi Arabia, Turkey, Taiwan, Indonesia,
Description
Table of Content
Tables & Figures
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
Market Analysis and Insights: Global Travelers Vaccines Market

Due to the COVID-19 pandemic, the global Travelers Vaccines market size is estimated to be worth US$ 3684.4 million in 2022 and is forecast to a readjusted size of US$ 6111.4 million by 2028 with a CAGR of 8.8% during the review period.

Fully considering the economic change by this health crisis, Meningococcal Vaccine accounting for % of the Travelers Vaccines global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Tourists segment is altered to an % CAGR throughout this forecast period.
Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.
Global Travelers Vaccines Scope and Segment
Travelers Vaccines market is segmented by Type and by End Users. Players, stakeholders, and other participants in the global Travelers Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by End Users for the period 2017-2028.

Segment by Type

Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other

Segment by End Users

Tourists
Students
Workers
Others

BY COMPANY

GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Travelers Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Travelers Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Meningococcal Vaccine
1.2.3 Japanese Encephalitis Vaccine
1.2.4 Yellow Fever Vaccine
1.2.5 Hepatitis Vaccine
1.2.6 Cholera Vaccine
1.2.7 Other
1.3 Market by End Users
1.3.1 Global Travelers Vaccines Market Size Growth Rate by End Users, 2017 VS 2021 VS 2028
1.3.2 Tourists
1.3.3 Students
1.3.4 Workers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Travelers Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Travelers Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Travelers Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Travelers Vaccines Sales by Region
2.4.1 Global Travelers Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Travelers Vaccines by Region (2023-2028)
2.5 Global Travelers Vaccines Revenue by Region
2.5.1 Global Travelers Vaccines Revenue by Region (2017-2022)
2.5.2 Global Travelers Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Travelers Vaccines Sales by Manufacturers
3.1.1 Global Top Travelers Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Travelers Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Travelers Vaccines in 2021
3.2 Global Travelers Vaccines Revenue by Manufacturers
3.2.1 Global Travelers Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Travelers Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Travelers Vaccines Revenue in 2021
3.3 Global Travelers Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Travelers Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Travelers Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Travelers Vaccines Sales by Type
4.1.1 Global Travelers Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Travelers Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Travelers Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Travelers Vaccines Revenue by Type
4.2.1 Global Travelers Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Travelers Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Travelers Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Travelers Vaccines Price by Type
4.3.1 Global Travelers Vaccines Price by Type (2017-2022)
4.3.2 Global Travelers Vaccines Price Forecast by Type (2023-2028)
5 Market Size by End Users
5.1 Global Travelers Vaccines Sales by End Users
5.1.1 Global Travelers Vaccines Historical Sales by End Users (2017-2022)
5.1.2 Global Travelers Vaccines Forecasted Sales by End Users (2023-2028)
5.1.3 Global Travelers Vaccines Sales Market Share by End Users (2017-2028)
5.2 Global Travelers Vaccines Revenue by End Users
5.2.1 Global Travelers Vaccines Historical Revenue by End Users (2017-2022)
5.2.2 Global Travelers Vaccines Forecasted Revenue by End Users (2023-2028)
5.2.3 Global Travelers Vaccines Revenue Market Share by End Users (2017-2028)
5.3 Global Travelers Vaccines Price by End Users
5.3.1 Global Travelers Vaccines Price by End Users (2017-2022)
5.3.2 Global Travelers Vaccines Price Forecast by End Users (2023-2028)
6 North America
6.1 North America Travelers Vaccines Market Size by Type
6.1.1 North America Travelers Vaccines Sales by Type (2017-2028)
6.1.2 North America Travelers Vaccines Revenue by Type (2017-2028)
6.2 North America Travelers Vaccines Market Size by End Users
6.2.1 North America Travelers Vaccines Sales by End Users (2017-2028)
6.2.2 North America Travelers Vaccines Revenue by End Users (2017-2028)
6.3 North America Travelers Vaccines Market Size by Country
6.3.1 North America Travelers Vaccines Sales by Country (2017-2028)
6.3.2 North America Travelers Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Travelers Vaccines Market Size by Type
7.1.1 Europe Travelers Vaccines Sales by Type (2017-2028)
7.1.2 Europe Travelers Vaccines Revenue by Type (2017-2028)
7.2 Europe Travelers Vaccines Market Size by End Users
7.2.1 Europe Travelers Vaccines Sales by End Users (2017-2028)
7.2.2 Europe Travelers Vaccines Revenue by End Users (2017-2028)
7.3 Europe Travelers Vaccines Market Size by Country
7.3.1 Europe Travelers Vaccines Sales by Country (2017-2028)
7.3.2 Europe Travelers Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Travelers Vaccines Market Size by Type
8.1.1 Asia Pacific Travelers Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Travelers Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Travelers Vaccines Market Size by End Users
8.2.1 Asia Pacific Travelers Vaccines Sales by End Users (2017-2028)
8.2.2 Asia Pacific Travelers Vaccines Revenue by End Users (2017-2028)
8.3 Asia Pacific Travelers Vaccines Market Size by Region
8.3.1 Asia Pacific Travelers Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Travelers Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Travelers Vaccines Market Size by Type
9.1.1 Latin America Travelers Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Travelers Vaccines Revenue by Type (2017-2028)
9.2 Latin America Travelers Vaccines Market Size by End Users
9.2.1 Latin America Travelers Vaccines Sales by End Users (2017-2028)
9.2.2 Latin America Travelers Vaccines Revenue by End Users (2017-2028)
9.3 Latin America Travelers Vaccines Market Size by Country
9.3.1 Latin America Travelers Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Travelers Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Travelers Vaccines Market Size by Type
10.1.1 Middle East and Africa Travelers Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Travelers Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Travelers Vaccines Market Size by End Users
10.2.1 Middle East and Africa Travelers Vaccines Sales by End Users (2017-2028)
10.2.2 Middle East and Africa Travelers Vaccines Revenue by End Users (2017-2028)
10.3 Middle East and Africa Travelers Vaccines Market Size by Country
10.3.1 Middle East and Africa Travelers Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Travelers Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Travelers Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Travelers Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 Sanofi Pasteur
11.2.1 Sanofi Pasteur Corporation Information
11.2.2 Sanofi Pasteur Overview
11.2.3 Sanofi Pasteur Travelers Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi Pasteur Travelers Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Pasteur Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Travelers Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Travelers Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Travelers Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer Travelers Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 CNBG
11.5.1 CNBG Corporation Information
11.5.2 CNBG Overview
11.5.3 CNBG Travelers Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CNBG Travelers Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CNBG Recent Developments
11.6 Sanofi Pasteur MSD
11.6.1 Sanofi Pasteur MSD Corporation Information
11.6.2 Sanofi Pasteur MSD Overview
11.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sanofi Pasteur MSD Travelers Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sanofi Pasteur MSD Recent Developments
11.7 Serum Institute of India
11.7.1 Serum Institute of India Corporation Information
11.7.2 Serum Institute of India Overview
11.7.3 Serum Institute of India Travelers Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Serum Institute of India Travelers Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Serum Institute of India Recent Developments
11.8 Biokangtai
11.8.1 Biokangtai Corporation Information
11.8.2 Biokangtai Overview
11.8.3 Biokangtai Travelers Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Biokangtai Travelers Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Biokangtai Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Travelers Vaccines Industry Chain Analysis
12.2 Travelers Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Travelers Vaccines Production Mode & Process
12.4 Travelers Vaccines Sales and Marketing
12.4.1 Travelers Vaccines Sales Channels
12.4.2 Travelers Vaccines Distributors
12.5 Travelers Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Travelers Vaccines Industry Trends
13.2 Travelers Vaccines Market Drivers
13.3 Travelers Vaccines Market Challenges
13.4 Travelers Vaccines Market Restraints
14 Key Findings in The Global Travelers Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Travelers Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Meningococcal Vaccine
    Table 3. Major Manufacturers of Japanese Encephalitis Vaccine
    Table 4. Major Manufacturers of Yellow Fever Vaccine
    Table 5. Major Manufacturers of Hepatitis Vaccine
    Table 6. Major Manufacturers of Cholera Vaccine
    Table 7. Major Manufacturers of Other
    Table 8. Global Travelers Vaccines Market Size Growth Rate by End Users, 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Travelers Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 10. Global Travelers Vaccines Sales by Region (2017-2022) & (K Doses)
    Table 11. Global Travelers Vaccines Sales Market Share by Region (2017-2022)
    Table 12. Global Travelers Vaccines Sales by Region (2023-2028) & (K Doses)
    Table 13. Global Travelers Vaccines Sales Market Share by Region (2023-2028)
    Table 14. Global Travelers Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 15. Global Travelers Vaccines Revenue Market Share by Region (2017-2022)
    Table 16. Global Travelers Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 17. Global Travelers Vaccines Revenue Market Share by Region (2023-2028)
    Table 18. Global Travelers Vaccines Sales by Manufacturers (2017-2022) & (K Doses)
    Table 19. Global Travelers Vaccines Sales Share by Manufacturers (2017-2022)
    Table 20. Global Travelers Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 21. Global Travelers Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 22. Travelers Vaccines Price by Manufacturers (2017-2022) &(USD/Dose)
    Table 23. Global Travelers Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Travelers Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Travelers Vaccines as of 2021)
    Table 25. Travelers Vaccines Manufacturing Base Distribution and Headquarters
    Table 26. Manufacturers Travelers Vaccines Product Offered
    Table 27. Date of Manufacturers Enter into Travelers Vaccines Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Travelers Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 30. Global Travelers Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 31. Global Travelers Vaccines Sales Share by Type (2017-2022)
    Table 32. Global Travelers Vaccines Sales Share by Type (2023-2028)
    Table 33. Global Travelers Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 34. Global Travelers Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 35. Global Travelers Vaccines Revenue Share by Type (2017-2022)
    Table 36. Global Travelers Vaccines Revenue Share by Type (2023-2028)
    Table 37. Travelers Vaccines Price by Type (2017-2022) & (USD/Dose)
    Table 38. Global Travelers Vaccines Price Forecast by Type (2023-2028) & (USD/Dose)
    Table 39. Global Travelers Vaccines Sales by End Users (2017-2022) & (K Doses)
    Table 40. Global Travelers Vaccines Sales by End Users (2023-2028) & (K Doses)
    Table 41. Global Travelers Vaccines Sales Share by End Users (2017-2022)
    Table 42. Global Travelers Vaccines Sales Share by End Users (2023-2028)
    Table 43. Global Travelers Vaccines Revenue by End Users (2017-2022) & (US$ Million)
    Table 44. Global Travelers Vaccines Revenue by End Users (2023-2028) & (US$ Million)
    Table 45. Global Travelers Vaccines Revenue Share by End Users (2017-2022)
    Table 46. Global Travelers Vaccines Revenue Share by End Users (2023-2028)
    Table 47. Travelers Vaccines Price by End Users (2017-2022) & (USD/Dose)
    Table 48. Global Travelers Vaccines Price Forecast by End Users (2023-2028) & (USD/Dose)
    Table 49. North America Travelers Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 50. North America Travelers Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 51. North America Travelers Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 52. North America Travelers Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 53. North America Travelers Vaccines Sales by End Users (2017-2022) & (K Doses)
    Table 54. North America Travelers Vaccines Sales by End Users (2023-2028) & (K Doses)
    Table 55. North America Travelers Vaccines Revenue by End Users (2017-2022) & (US$ Million)
    Table 56. North America Travelers Vaccines Revenue by End Users (2023-2028) & (US$ Million)
    Table 57. North America Travelers Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 58. North America Travelers Vaccines Sales by Country (2023-2028) & (K Doses)
    Table 59. North America Travelers Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 60. North America Travelers Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 61. Europe Travelers Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 62. Europe Travelers Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 63. Europe Travelers Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 64. Europe Travelers Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 65. Europe Travelers Vaccines Sales by End Users (2017-2022) & (K Doses)
    Table 66. Europe Travelers Vaccines Sales by End Users (2023-2028) & (K Doses)
    Table 67. Europe Travelers Vaccines Revenue by End Users (2017-2022) & (US$ Million)
    Table 68. Europe Travelers Vaccines Revenue by End Users (2023-2028) & (US$ Million)
    Table 69. Europe Travelers Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 70. Europe Travelers Vaccines Sales by Country (2023-2028) & (K Doses)
    Table 71. Europe Travelers Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 72. Europe Travelers Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Travelers Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 74. Asia Pacific Travelers Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 75. Asia Pacific Travelers Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Travelers Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Travelers Vaccines Sales by End Users (2017-2022) & (K Doses)
    Table 78. Asia Pacific Travelers Vaccines Sales by End Users (2023-2028) & (K Doses)
    Table 79. Asia Pacific Travelers Vaccines Revenue by End Users (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Travelers Vaccines Revenue by End Users (2023-2028) & (US$ Million)
    Table 81. Asia Pacific Travelers Vaccines Sales by Region (2017-2022) & (K Doses)
    Table 82. Asia Pacific Travelers Vaccines Sales by Region (2023-2028) & (K Doses)
    Table 83. Asia Pacific Travelers Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 84. Asia Pacific Travelers Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 85. Latin America Travelers Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 86. Latin America Travelers Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 87. Latin America Travelers Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 88. Latin America Travelers Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 89. Latin America Travelers Vaccines Sales by End Users (2017-2022) & (K Doses)
    Table 90. Latin America Travelers Vaccines Sales by End Users (2023-2028) & (K Doses)
    Table 91. Latin America Travelers Vaccines Revenue by End Users (2017-2022) & (US$ Million)
    Table 92. Latin America Travelers Vaccines Revenue by End Users (2023-2028) & (US$ Million)
    Table 93. Latin America Travelers Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 94. Latin America Travelers Vaccines Sales by Country (2023-2028) & (K Doses)
    Table 95. Latin America Travelers Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 96. Latin America Travelers Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Travelers Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 98. Middle East and Africa Travelers Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 99. Middle East and Africa Travelers Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Travelers Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Travelers Vaccines Sales by End Users (2017-2022) & (K Doses)
    Table 102. Middle East and Africa Travelers Vaccines Sales by End Users (2023-2028) & (K Doses)
    Table 103. Middle East and Africa Travelers Vaccines Revenue by End Users (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Travelers Vaccines Revenue by End Users (2023-2028) & (US$ Million)
    Table 105. Middle East and Africa Travelers Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 106. Middle East and Africa Travelers Vaccines Sales by Country (2023-2028) & (K Doses)
    Table 107. Middle East and Africa Travelers Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 108. Middle East and Africa Travelers Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 109. GlaxoSmithKline Corporation Information
    Table 110. GlaxoSmithKline Description and Major Businesses
    Table 111. GlaxoSmithKline Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 112. GlaxoSmithKline Travelers Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. GlaxoSmithKline Recent Developments
    Table 114. Sanofi Pasteur Corporation Information
    Table 115. Sanofi Pasteur Description and Major Businesses
    Table 116. Sanofi Pasteur Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 117. Sanofi Pasteur Travelers Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Sanofi Pasteur Recent Developments
    Table 119. Merck Corporation Information
    Table 120. Merck Description and Major Businesses
    Table 121. Merck Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 122. Merck Travelers Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Merck Recent Developments
    Table 124. Pfizer Corporation Information
    Table 125. Pfizer Description and Major Businesses
    Table 126. Pfizer Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 127. Pfizer Travelers Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Pfizer Recent Developments
    Table 129. CNBG Corporation Information
    Table 130. CNBG Description and Major Businesses
    Table 131. CNBG Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 132. CNBG Travelers Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. CNBG Recent Developments
    Table 134. Sanofi Pasteur MSD Corporation Information
    Table 135. Sanofi Pasteur MSD Description and Major Businesses
    Table 136. Sanofi Pasteur MSD Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 137. Sanofi Pasteur MSD Travelers Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Sanofi Pasteur MSD Recent Developments
    Table 139. Serum Institute of India Corporation Information
    Table 140. Serum Institute of India Description and Major Businesses
    Table 141. Serum Institute of India Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 142. Serum Institute of India Travelers Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Serum Institute of India Recent Developments
    Table 144. Biokangtai Corporation Information
    Table 145. Biokangtai Description and Major Businesses
    Table 146. Biokangtai Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 147. Biokangtai Travelers Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Biokangtai Recent Developments
    Table 149. Key Raw Materials Lists
    Table 150. Raw Materials Key Suppliers Lists
    Table 151. Travelers Vaccines Distributors List
    Table 152. Travelers Vaccines Customers List
    Table 153. Travelers Vaccines Market Trends
    Table 154. Travelers Vaccines Market Drivers
    Table 155. Travelers Vaccines Market Challenges
    Table 156. Travelers Vaccines Market Restraints
    Table 157. Research Programs/Design for This Report
    Table 158. Key Data Information from Secondary Sources
    Table 159. Key Data Information from Primary Sources
List of Figures
    Figure 1. Travelers Vaccines Product Picture
    Figure 3. Global Travelers Vaccines Market Share by Type in 2021 & 2028
    Figure 3. Meningococcal Vaccine Product Picture
    Figure 4. Japanese Encephalitis Vaccine Product Picture
    Figure 5. Yellow Fever Vaccine Product Picture
    Figure 6. Hepatitis Vaccine Product Picture
    Figure 7. Cholera Vaccine Product Picture
    Figure 8. Other Product Picture
    Figure 9. Global Travelers Vaccines Market Share by End Users in 2021 & 2028
    Figure 10. Tourists
    Figure 11. Students
    Figure 12. Workers
    Figure 13. Others
    Figure 14. Travelers Vaccines Report Years Considered
    Figure 15. Global Travelers Vaccines Sales 2017-2028 (K Doses)
    Figure 16. Global Travelers Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Travelers Vaccines Revenue 2017-2028 (US$ Million)
    Figure 18. Global Travelers Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 19. Global Travelers Vaccines Sales Market Share by Region (2017-2022)
    Figure 20. Global Travelers Vaccines Sales Market Share by Region (2023-2028)
    Figure 21. North America Travelers Vaccines Sales YoY (2017-2028) & (K Doses)
    Figure 22. North America Travelers Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Travelers Vaccines Sales YoY (2017-2028) & (K Doses)
    Figure 24. Europe Travelers Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Asia-Pacific Travelers Vaccines Sales YoY (2017-2028) & (K Doses)
    Figure 26. Asia-Pacific Travelers Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Latin America Travelers Vaccines Sales YoY (2017-2028) & (K Doses)
    Figure 28. Latin America Travelers Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Middle East & Africa Travelers Vaccines Sales YoY (2017-2028) & (K Doses)
    Figure 30. Middle East & Africa Travelers Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. The Travelers Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 32. The Top 5 and 10 Largest Manufacturers of Travelers Vaccines in the World: Market Share by Travelers Vaccines Revenue in 2021
    Figure 33. Global Travelers Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 34. Global Travelers Vaccines Sales Market Share by Type (2017-2028)
    Figure 35. Global Travelers Vaccines Revenue Market Share by Type (2017-2028)
    Figure 36. Global Travelers Vaccines Sales Market Share by End Users (2017-2028)
    Figure 37. Global Travelers Vaccines Revenue Market Share by End Users (2017-2028)
    Figure 38. North America Travelers Vaccines Sales Market Share by Type (2017-2028)
    Figure 39. North America Travelers Vaccines Revenue Market Share by Type (2017-2028)
    Figure 40. North America Travelers Vaccines Sales Market Share by End Users (2017-2028)
    Figure 41. North America Travelers Vaccines Revenue Market Share by End Users (2017-2028)
    Figure 42. North America Travelers Vaccines Sales Share by Country (2017-2028)
    Figure 43. North America Travelers Vaccines Revenue Share by Country (2017-2028)
    Figure 44. U.S. Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 45. Canada Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 46. Europe Travelers Vaccines Sales Market Share by Type (2017-2028)
    Figure 47. Europe Travelers Vaccines Revenue Market Share by Type (2017-2028)
    Figure 48. Europe Travelers Vaccines Sales Market Share by End Users (2017-2028)
    Figure 49. Europe Travelers Vaccines Revenue Market Share by End Users (2017-2028)
    Figure 50. Europe Travelers Vaccines Sales Share by Country (2017-2028)
    Figure 51. Europe Travelers Vaccines Revenue Share by Country (2017-2028)
    Figure 52. Germany Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 53. France Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 54. U.K. Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 55. Italy Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 56. Russia Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 57. Asia Pacific Travelers Vaccines Sales Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Travelers Vaccines Revenue Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Travelers Vaccines Sales Market Share by End Users (2017-2028)
    Figure 60. Asia Pacific Travelers Vaccines Revenue Market Share by End Users (2017-2028)
    Figure 61. Asia Pacific Travelers Vaccines Sales Share by Region (2017-2028)
    Figure 62. Asia Pacific Travelers Vaccines Revenue Share by Region (2017-2028)
    Figure 63. China Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 64. Japan Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 65. South Korea Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 66. India Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 67. Australia Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 68. Taiwan Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 69. Indonesia Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 70. Thailand Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 71. Malaysia Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 72. Philippines Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 73. Latin America Travelers Vaccines Sales Market Share by Type (2017-2028)
    Figure 74. Latin America Travelers Vaccines Revenue Market Share by Type (2017-2028)
    Figure 75. Latin America Travelers Vaccines Sales Market Share by End Users (2017-2028)
    Figure 76. Latin America Travelers Vaccines Revenue Market Share by End Users (2017-2028)
    Figure 77. Latin America Travelers Vaccines Sales Share by Country (2017-2028)
    Figure 78. Latin America Travelers Vaccines Revenue Share by Country (2017-2028)
    Figure 79. Mexico Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 80. Brazil Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 81. Argentina Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 82. Middle East and Africa Travelers Vaccines Sales Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Travelers Vaccines Revenue Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Travelers Vaccines Sales Market Share by End Users (2017-2028)
    Figure 85. Middle East and Africa Travelers Vaccines Revenue Market Share by End Users (2017-2028)
    Figure 86. Middle East and Africa Travelers Vaccines Sales Share by Country (2017-2028)
    Figure 87. Middle East and Africa Travelers Vaccines Revenue Share by Country (2017-2028)
    Figure 88. Turkey Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 89. Saudi Arabia Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 90. U.A.E Travelers Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 91. Travelers Vaccines Value Chain
    Figure 92. Travelers Vaccines Production Process
    Figure 93. Channels of Distribution
    Figure 94. Distributors Profiles
    Figure 95. Bottom-up and Top-down Approaches for This Report
    Figure 96. Data Triangulation
    Figure 97. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String

RELATED REPORTS

Global Vaccine Temperature Monitoring System Market Insights Forecast to 2028
Global Vaccine Temperature Monitoring System Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-10F7540
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Nelfinavir Market Insights Forecast to 2028
Global Nelfinavir Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-25I7469
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Vancomycin Market Insights and Forecast to 2028
Global Vancomycin Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-20N7760
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Hepatitis B Human Immunoglobulin Market Insights and Forecast to 2028
Global Hepatitis B Human Immunoglobulin Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-22V7718
Tue May 03 00:00:00 UTC 2022

Add to Cart